However, because IGFBP-2 could create a microenvironment that is more favorable to invasion and metastasis through the up-regulation of MMP-2, the adipocytes may become a new target to reduce the extent of breast cancer metastasis. Here, IGFBP2 is linked to breast carcinoma.